Delta Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $116K | Buy |
2,104
+444
| +27% | +$24.1K | 0.01% | 192 |
|
|
2025
Q4 | $81.4K | Buy |
1,660
+4
| +0.2% | +$187 | 0.01% | 217 |
|
|
2025
Q3 | $71.5K | Buy |
1,656
+74
| +5% | +$2.89K | 0.01% | 232 |
|
|
2025
Q2 | $60.7K | Hold |
1,582
| – | – | 0.01% | 241 |
|
|
2025
Q1 | $61.3K | Buy |
1,582
+395
| +33% | +$14.5K | 0.01% | 229 |
|
|
2024
Q4 | $40.1K | Sell |
1,187
-37
| -3% | -$1.33K | ﹤0.01% | 284 |
|
|
2024
Q3 | $50K | Hold |
1,224
| – | – | ﹤0.01% | 269 |
|
|
2024
Q2 | $47.1K | Sell |
1,224
-1,469
| -55% | -$61.8K | ﹤0.01% | 271 |
|
|
2024
Q1 | $115K | Sell |
2,693
-11
| -0.4% | -$454 | 0.01% | 180 |
|
|
2023
Q4 | $100K | Sell |
2,704
-219
| -7% | -$7.86K | 0.01% | 194 |
|
|
2023
Q3 | $106K | Sell |
2,923
-3,402
| -54% | -$121K | 0.01% | 175 |
|
|
2023
Q2 | $225K | Sell |
6,325
-920
| -13% | -$33K | 0.02% | 128 |
|
|
2023
Q1 | $258K | Sell |
7,245
-800
| -10% | -$28K | 0.03% | 117 |
|
|
2022
Q4 | $283K | Hold |
8,045
| – | – | 0.03% | 115 |
|
|
2022
Q3 | $237K | Sell |
8,045
-46
| -0.6% | -$1.74K | 0.03% | 121 |
|
|
2022
Q2 | $440K | Sell |
8,091
-40
| -0.5% | -$2.21K | 0.05% | 90 |
|
|
2022
Q1 | $443K | Sell |
8,131
-140
| -2% | -$7.6K | 0.04% | 96 |
|
|
2021
Q4 | $456K | Hold |
8,271
| – | – | 0.04% | 99 |
|
|
2021
Q3 | $395K | Buy |
8,271
+396
| +5% | +$19.9K | 0.04% | 98 |
|
|
2021
Q2 | $392K | Buy |
7,875
+108
| +1% | +$5.19K | 0.04% | 101 |
|
|
2021
Q1 | $347K | Buy |
7,767
+80
| +1% | +$3.63K | 0.04% | 108 |
|
|
2020
Q4 | $354K | Buy |
7,687
+440
| +6% | +$20.2K | 0.04% | 105 |
|
|
2020
Q3 | $341K | Sell |
7,247
-32
| -0.4% | -$1.6K | 0.04% | 97 |
|
|
2020
Q2 | $371K | Buy |
7,279
+156
| +2% | +$8K | 0.05% | 89 |
|
|
2020
Q1 | $337K | Sell |
7,123
-20
| -0.3% | -$1.07K | 0.05% | 87 |
|
|
2019
Q4 | $420K | Buy |
7,143
+112
| +2% | +$6.23K | 0.05% | 95 |
|
|
2019
Q3 | $375K | Buy |
7,031
+238
| +4% | +$12.2K | 0.05% | 101 |
|
|
2019
Q2 | $340K | Sell |
6,793
-32
| -0.5% | -$1.61K | 0.05% | 100 |
|
|
2019
Q1 | $357K | Sell |
6,825
-1,520
| -18% | -$76K | 0.05% | 96 |
|
|
2018
Q4 | $398K | Sell |
8,345
-12
| -0.1% | -$591 | 0.06% | 85 |
|
|
2018
Q3 | $419K | Buy |
8,357
+216
| +3% | +$11K | 0.06% | 88 |
|
|
2018
Q2 | $410K | Sell |
8,141
-228
| -3% | -$11.5K | 0.06% | 84 |
|
|
2018
Q1 | $409K | Buy |
8,369
+39
| +0.5% | +$1.82K | 0.06% | 86 |
|
|
2017
Q4 | $370K | Sell |
8,330
-485
| -6% | -$22.4K | 0.05% | 89 |
|
|
2017
Q3 | $448K | Sell |
8,815
-19
| -0.2% | -$964 | 0.07% | 77 |
|
|
2017
Q2 | $477K | Buy |
8,834
+1
| +0% | +$53 | 0.07% | 76 |
|
|
2017
Q1 | $465K | Sell |
8,833
-51
| -0.6% | -$2.59K | 0.07% | 76 |
|
|
2016
Q4 | $427K | Buy |
8,884
+41
| +0.5% | +$2.02K | 0.07% | 78 |
|
|
2016
Q3 | $477K | Buy |
8,843
+281
| +3% | +$15.4K | 0.08% | 75 |
|
|
2016
Q2 | $464K | Hold |
8,562
| – | – | 0.08% | 75 |
|
|
2016
Q1 | $434K | Sell |
8,562
-196
| -2% | -$9.76K | 0.08% | 75 |
|
|
2015
Q4 | $441K | Buy |
8,758
+200
| +2% | +$10.2K | 0.08% | 76 |
|
|
2015
Q3 | $411K | Buy |
8,558
+2,460
| +40% | +$128K | 0.08% | 80 |
|
|
2015
Q2 | $317K | Buy |
6,098
+2,224
| +57% | +$125K | 0.06% | 85 |
|
|
2015
Q1 | $223K | Buy |
3,874
+1,956
| +102% | +$112K | 0.04% | 96 |
|
|
2014
Q4 | $102K | Sell |
1,918
-32
| -2% | -$1.79K | 0.02% | 156 |
|
|
2014
Q3 | $112K | Sell |
1,950
-160
| -8% | -$9.81K | 0.02% | 145 |
|
|
2014
Q2 | $141K | Sell |
2,110
-80
| -4% | -$5.42K | 0.03% | 128 |
|
|
2014
Q1 | $146K | Buy |
2,190
+112
| +5% | +$7.57K | 0.03% | 122 |
|
|
2013
Q4 | $139K | Buy |
2,078
+128
| +7% | +$8.3K | 0.03% | 126 |
|
|
2013
Q3 | $122K | Sell |
1,950
-60
| -3% | -$3.86K | 0.03% | 133 |
|
|
2013
Q2 | $126K | Buy |
+2,010
| New | +$128K | 0.03% | 128 |
|
Other funds holding GSK
JEST
Delta Asset Management's GSK Position: Q1 2026 in Review
Delta Asset Management increased its GSK (GSK) stake by 27% in Q1 2026, buying an estimated $24.1K and bringing the position to 2,104 shares worth $116K. The position accounts for 0.01% of the portfolio, ranked #192.
Delta Asset Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $477K in Q2 2017. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Delta Asset Management held 2,104 shares of GSK worth $116K as of Q1 2026.
- Delta Asset Management bought 444 GSK shares in Q1 2026, an estimated $24.1K.
- GSK made up 0.01% of Delta Asset Management's portfolio in Q1 2026, its #192 holding.
- Delta Asset Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
- Delta Asset Management's GSK position peaked at $477K in Q2 2017.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Delta Asset Management's 13F filing for Q1 2026, filed 11 May 2026.